REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$11.58
0.36 (3.21%)
▲
5d:
+4.04%
30d:
+30.55%
90d:
+52.17%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 02, 2026
0d
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: REPL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: REPL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $11.58, which is considered extended relative to its 30-day fair value range of $7.42 to $11.37.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $9.88, while resistance sits at $12.50. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $9.88, while resistance sits at $12.50. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.42 -
$11.37
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.4%
Protect Your Profits
REPL is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BEARISH: Trading above Wall St target ($10.67)
Trading Range Analysis
30-Day Trading Range
$7.42 -
$11.37
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.88
Resistance Level
$12.50
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.55
Wall Street Target
$10.67
(-7.9%)
Share & Embed Analysis
Last updated: July 04, 2026 1:27 AM ET
Data refreshes hourly during market hours. Next update: 2:27 AM
Data refreshes hourly during market hours. Next update: 2:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Sarchi
SELL
6500 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$189 | 62 BUY |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
